LSBio provides high-quality antibodies, tissue arrays, and immunohistochemistry (IHC) data and services to researchers worldwide.
Founded in 1995 by Drs. Joseph Brown and Glenna Burmer, LSBio was established as a molecular pathology company with a focus on protein localization in diseased human tissues by IHC. Through the experience gained by executing thousands of IHC studies, and generating and testing many thousands of antibodies, LSBio has become a world leader in the antibody industry, with a reputation for excellence. LSBio has a catalog of 101,500 monoclonal and polyclonal antibodies to 16,500 targets. Antibodies are available for most species and all major research applications, such as immunoblotting, IHC, immunofluorescence, and fluorescence-activated cell sorting. Through extensive ongoing in-house testing, more than 6,300 of these antibodies have also been identified as exceptional IHC reagents, and given the IHC-plus™ brand. More than 500 tissue arrays are also available from LSBio, providing researchers with a cost-effective and time saving resource for researching protein localization and expression in all major normal human tissue types and cancers. For more than a decade researchers have been relying upon LSBio’s expertise to fulfill their molecular pathology outsourcing needs. LSBio’s services include: antibody production and characterization, custom IHC studies supported by a massive archival human tissue bank, tissue-cross reactivity screening, and standard histology procedures and pathology analysis. LSBio stands behind the quality of its products and services and offers unparalleled customer service and support. In the years to come, LSBio plans to continue expanding its catalog of high-quality proteomics products, with a focus on IHC-validated antibodies, providing its customers with excellent reagents, services, and support to accelerate their research.